Opus Genetics OCUP Stock
Opus Genetics Price Chart
Opus Genetics OCUP Financial and Trading Overview
| Opus Genetics stock price | 1.17 USD |
| Previous Close | 3.86 USD |
| Open | 3.85 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 800 |
| Day's Range | 3.77 - 4 USD |
| 52 Week Range | 1.81 - 6.6 USD |
| Volume | 137.53K USD |
| Avg. Volume | 387.82K USD |
| Market Cap | 83.6M USD |
| Beta (5Y Monthly) | 0.020714 |
| PE Ratio (TTM) | 4.2000003 |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.2 USD |
OCUP Valuation Measures
| Enterprise Value | 41.87M USD |
| Trailing P/E | 4.2000003 |
| Forward P/E | -12.090909 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.0096464 |
| Price/Book (mrq) | 2.0264094 |
| Enterprise Value/Revenue | 1.006 |
| Enterprise Value/EBITDA | 2.25 |
Trading Information
Opus Genetics Stock Price History
| Beta (5Y Monthly) | 0.020714 |
| 52-Week Change | 103.57% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.6 USD |
| 52 Week Low | 1.81 USD |
| 50-Day Moving Average | 4.9 USD |
| 200-Day Moving Average | 3.47 USD |
OCUP Share Statistics
| Avg. Volume (3 month) | 387.82K USD |
| Avg. Daily Volume (10-Days) | 184.37K USD |
| Shares Outstanding | 20.95M |
| Float | 20.14M |
| Short Ratio | 3.3 |
| % Held by Insiders | 5.20% |
| % Held by Institutions | 16.67% |
| Shares Short | 1.54M |
| Short % of Float | 7.58% |
| Short % of Shares Outstanding | 7.33% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 44.93% |
| Operating Margin (ttm) | 44.71% |
| Gross Margin | 63.51% |
| EBITDA Margin | 44.72% |
Management Effectiveness
| Return on Assets (ttm) | 35.29% |
| Return on Equity (ttm) | 63.88% |
Income Statement
| Revenue (ttm) | 41.6M USD |
| Revenue Per Share (ttm) | 2.04 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | 18.61M USD |
| Net Income Avi to Common (ttm) | 18.69M USD |
| Diluted EPS (ttm) | 0.95 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 39.01M USD |
| Total Cash Per Share (mrq) | 1.86 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 10.929 |
| Book Value Per Share (mrq) | 1.969 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 16.84M USD |
| Levered Free Cash Flow (ttm) | 9.66M USD |
Profile of Opus Genetics
| Country | United States |
| State | MI |
| City | Farmington Hills |
| Address | 37000 Grand River Avenue |
| ZIP | 48335 |
| Phone | 248 681 9815 |
| Website | https://www.ocuphire.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate for dim light or night vision disturbances; and for pharmacologically induced mydriasis and presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. The company is headquartered in Farmington Hills, Michigan.
Q&A For Opus Genetics Stock
What is a current OCUP stock price?
Opus Genetics OCUP stock price today per share is 1.17 USD.
How to purchase Opus Genetics stock?
You can buy OCUP shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Opus Genetics?
The stock symbol or ticker of Opus Genetics is OCUP.
Which industry does the Opus Genetics company belong to?
The Opus Genetics industry is Biotechnology.
How many shares does Opus Genetics have in circulation?
The max supply of Opus Genetics shares is 27.13M.
What is Opus Genetics Price to Earnings Ratio (PE Ratio)?
Opus Genetics PE Ratio is 0.00000000 now.
What was Opus Genetics earnings per share over the trailing 12 months (TTM)?
Opus Genetics EPS is 0 USD over the trailing 12 months.
Which sector does the Opus Genetics company belong to?
The Opus Genetics sector is Healthcare.
Opus Genetics OCUP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}